Acute Dosing of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-003)
Clinical trial NCT01934647 · TERMINATED
Trial details
- NCT number
- NCT01934647
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-22
- Primary completion
- 2014-09-08
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.